clear

Current Filters

Showing 1 - 10 results of 1084

Caprelsa for Medullary Thyroid Cancer – Details (Caprelsa) (Last Updated: Apr 17, 2017)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Caprelsa
Manufacturer:
Sanofi Genzyme
Submission Type:
Initial

Fentanyl buccal (Fentora) (Last Updated: Jun 10, 2016)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Fentora
Manufacturer:
Teva Canada Innovation
Submission Type:
Initial
Indications:

Pain (breakthrough), cancer (adults)

Edoxaban (Lixiana VTE) (Last Updated: Jun 8, 2016)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Lixiana VTE
Manufacturer:
Daiichi Sankyo, Inc.
Submission Type:
Initial
Indications:

Venous thromboembolism, treatment and recurrence prevention

Edoxaban (Lixiana NVAF) (Last Updated: Jun 8, 2016)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Lixiana NVAF
Manufacturer:
Daiichi Sankyo, Inc.
Submission Type:
Initial
Indications:

Nonvalvular atrial fibrillation, prevention of stroke and systemic embolism

Daclizumab beta (Zinbryta) (Last Updated: Oct 18, 2016)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Zinbryta
Manufacturer:
Biogen Canada Inc.
Submission Type:
Initial
Indications:

Multiple Sclerosis, relapsing

Ivabradine (Lancora) (Last Updated: Oct 11, 2016)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Lancora
Manufacturer:
Servier Canada Inc.
Submission Type:
Initial
Indications:

Heart failure, NYHA class II or III

Mifepristone and misoprostol (Mifegymiso) (Last Updated: Apr 20, 2017)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Mifegymiso
Manufacturer:
Celopharma Inc.
Submission Type:
Initial
Indications:

Medical termination of pregnancy

Download results as CSV